New Malaria vaccine confirmed to be effective and safe

The National Institute of Allergy and Infectious Diseases (NIAID) confirmed that the new malaria vaccine PfSPZ is safe to use and effective in providing protection against malaria. Based on results from an early stage clinical trial, researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, confirmed that the new PfSPZ Vaccine developed by scientists at Sanaria is effective and safe to use. Malaria is caused by mosquitoes. When a mosquito bites a human, malaria parasites in the immature, sporozoite stage of their life cycle enter the body. They first travel to the liver where they multiply and then spread throughout the body through the bloodstream. PfSPZ is a new malaria vaccine made from weak sporozoites of the species Plasmodium falciparum, the most deadly of the malaria-causing parasites. “The global burden of malaria is extraordinary and unacceptable,” said NIAID Director Anthony S. Fauci, in a press...